APOE and atherosclerosis: More recently, it has been shown that intraperitoneal administration of aqueous infusion of KLEPTOSE® CRYSMEB (commercial name of MβCD from Rochètte Freres, Lestrem, France) were able to efficiently reduce atherosclerosis in ApoE−/− male mice (class of mice often employed as in vivo models for atherosclerosis).